vs
通用电气医疗（OPCH）与SCANSOURCE, INC.（SCSC）财务数据对比。点击上方公司名可切换其他公司
通用电气医疗的季度营收约是SCANSOURCE, INC.的1.9倍（$1.4B vs $766.5M），通用电气医疗净利率更高（3.6% vs 2.2%，领先1.5%），通用电气医疗同比增速更快（12.2% vs 2.5%），通用电气医疗自由现金流更多（$130.2M vs $28.9M），过去两年通用电气医疗的营收复合增速更高（13.0% vs 0.9%）
通用电气医疗是总部位于美国伊利诺伊州芝加哥的医疗科技企业，旗下设四大业务板块：医学影像（含分子成像、CT、磁共振、女性健康筛查及X线设备）、超声、患者护理解决方案（覆盖远程患者监测、麻醉呼吸护理、心脏病诊断、婴儿护理等）及制药相关业务。
ScanSource是全球领先的专业技术分销商，主营销售点系统、条码扫描设备、网络安全产品、云服务及通信解决方案，面向北美、拉美、欧洲的增值经销商、服务提供商及企业客户，覆盖零售、医疗、工业、公共部门等领域。
OPCH vs SCSC — 直观对比
营收规模更大
OPCH
是对方的1.9倍
$766.5M
营收增速更快
OPCH
高出9.7%
2.5%
净利率更高
OPCH
高出1.5%
2.2%
自由现金流更多
OPCH
多$101.4M
$28.9M
两年增速更快
OPCH
近两年复合增速
0.9%
损益表 — Q3 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.4B | $766.5M |
| 净利润 | $51.8M | $16.5M |
| 毛利率 | 19.0% | 13.4% |
| 营业利润率 | 5.9% | 2.3% |
| 净利率 | 3.6% | 2.2% |
| 营收同比 | 12.2% | 2.5% |
| 净利润同比 | -3.8% | -3.3% |
| 每股收益（稀释后） | $0.32 | $0.75 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OPCHSCSC
| Q4 25 | — | $766.5M | ||
| Q3 25 | $1.4B | $739.6M | ||
| Q2 25 | $1.4B | $812.9M | ||
| Q1 25 | $1.3B | $704.8M | ||
| Q4 24 | $1.3B | $747.5M | ||
| Q3 24 | $1.3B | $775.6M | ||
| Q2 24 | $1.2B | $746.1M | ||
| Q1 24 | $1.1B | $752.6M |
净利润OPCHSCSC
| Q4 25 | — | $16.5M | ||
| Q3 25 | $51.8M | $19.9M | ||
| Q2 25 | $50.5M | $20.1M | ||
| Q1 25 | $46.7M | $17.4M | ||
| Q4 24 | $60.1M | $17.1M | ||
| Q3 24 | $53.9M | $17.0M | ||
| Q2 24 | $53.0M | $16.1M | ||
| Q1 24 | $44.8M | $12.8M |
毛利率OPCHSCSC
| Q4 25 | — | 13.4% | ||
| Q3 25 | 19.0% | 14.5% | ||
| Q2 25 | 19.0% | 12.9% | ||
| Q1 25 | 19.7% | 14.2% | ||
| Q4 24 | 21.3% | 13.6% | ||
| Q3 24 | 20.1% | 13.1% | ||
| Q2 24 | 20.3% | 13.0% | ||
| Q1 24 | 20.8% | 12.6% |
营业利润率OPCHSCSC
| Q4 25 | — | 2.3% | ||
| Q3 25 | 5.9% | 3.5% | ||
| Q2 25 | 5.8% | 3.3% | ||
| Q1 25 | 5.9% | 3.2% | ||
| Q4 24 | 6.9% | 2.5% | ||
| Q3 24 | 6.7% | 2.3% | ||
| Q2 24 | 6.6% | 2.9% | ||
| Q1 24 | 6.0% | 2.3% |
净利率OPCHSCSC
| Q4 25 | — | 2.2% | ||
| Q3 25 | 3.6% | 2.7% | ||
| Q2 25 | 3.6% | 2.5% | ||
| Q1 25 | 3.5% | 2.5% | ||
| Q4 24 | 4.8% | 2.3% | ||
| Q3 24 | 4.2% | 2.2% | ||
| Q2 24 | 4.3% | 2.2% | ||
| Q1 24 | 3.9% | 1.7% |
每股收益（稀释后）OPCHSCSC
| Q4 25 | — | $0.75 | ||
| Q3 25 | $0.32 | $0.89 | ||
| Q2 25 | $0.31 | $0.87 | ||
| Q1 25 | $0.28 | $0.74 | ||
| Q4 24 | $0.36 | $0.70 | ||
| Q3 24 | $0.31 | $0.69 | ||
| Q2 24 | $0.30 | $0.66 | ||
| Q1 24 | $0.26 | $0.50 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $309.8M | $83.5M |
| 总债务越低越好 | $1.2B | — |
| 股东权益账面价值 | $1.4B | $910.9M |
| 总资产 | $3.5B | $1.7B |
| 负债/权益比越低杠杆越低 | 0.86× | — |
8季度趋势，按日历期对齐
现金及短期投资OPCHSCSC
| Q4 25 | — | $83.5M | ||
| Q3 25 | $309.8M | $124.9M | ||
| Q2 25 | $198.8M | $126.2M | ||
| Q1 25 | $171.4M | $146.3M | ||
| Q4 24 | $412.6M | $110.5M | ||
| Q3 24 | $483.0M | $145.0M | ||
| Q2 24 | $376.9M | $185.5M | ||
| Q1 24 | $219.5M | $159.1M |
总债务OPCHSCSC
| Q4 25 | — | — | ||
| Q3 25 | $1.2B | — | ||
| Q2 25 | $1.1B | — | ||
| Q1 25 | $1.1B | — | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | $1.1B | — | ||
| Q2 24 | $1.1B | — | ||
| Q1 24 | $1.1B | — |
股东权益OPCHSCSC
| Q4 25 | — | $910.9M | ||
| Q3 25 | $1.4B | $914.0M | ||
| Q2 25 | $1.4B | $906.4M | ||
| Q1 25 | $1.4B | $901.7M | ||
| Q4 24 | $1.4B | $900.7M | ||
| Q3 24 | $1.4B | $920.9M | ||
| Q2 24 | $1.4B | $924.3M | ||
| Q1 24 | $1.4B | $944.1M |
总资产OPCHSCSC
| Q4 25 | — | $1.7B | ||
| Q3 25 | $3.5B | $1.7B | ||
| Q2 25 | $3.4B | $1.8B | ||
| Q1 25 | $3.3B | $1.7B | ||
| Q4 24 | $3.4B | $1.7B | ||
| Q3 24 | $3.4B | $1.8B | ||
| Q2 24 | $3.3B | $1.8B | ||
| Q1 24 | $3.2B | $1.8B |
负债/权益比OPCHSCSC
| Q4 25 | — | — | ||
| Q3 25 | 0.86× | — | ||
| Q2 25 | 0.82× | — | ||
| Q1 25 | 0.82× | — | ||
| Q4 24 | 0.79× | — | ||
| Q3 24 | 0.78× | — | ||
| Q2 24 | 0.79× | — | ||
| Q1 24 | 0.74× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $139.4M | $30.8M |
| 自由现金流经营现金流 - 资本支出 | $130.2M | $28.9M |
| 自由现金流率自由现金流/营收 | 9.1% | 3.8% |
| 资本支出强度资本支出/营收 | 0.6% | 0.3% |
| 现金转化率经营现金流/净利润 | 2.69× | 1.87× |
| 过去12个月自由现金流最近4个季度 | $220.7M | — |
8季度趋势，按日历期对齐
经营现金流OPCHSCSC
| Q4 25 | — | $30.8M | ||
| Q3 25 | $139.4M | $23.2M | ||
| Q2 25 | $90.3M | — | ||
| Q1 25 | $-7.2M | $66.1M | ||
| Q4 24 | $36.1M | $-6.2M | ||
| Q3 24 | $160.4M | $44.8M | ||
| Q2 24 | $195.7M | — | ||
| Q1 24 | $-68.8M | $160.2M |
自由现金流OPCHSCSC
| Q4 25 | — | $28.9M | ||
| Q3 25 | $130.2M | $20.8M | ||
| Q2 25 | $81.2M | — | ||
| Q1 25 | $-16.6M | $64.6M | ||
| Q4 24 | $25.8M | $-8.2M | ||
| Q3 24 | $150.7M | $42.5M | ||
| Q2 24 | $185.9M | — | ||
| Q1 24 | $-74.6M | $157.7M |
自由现金流率OPCHSCSC
| Q4 25 | — | 3.8% | ||
| Q3 25 | 9.1% | 2.8% | ||
| Q2 25 | 5.7% | — | ||
| Q1 25 | -1.2% | 9.2% | ||
| Q4 24 | 2.0% | -1.1% | ||
| Q3 24 | 11.8% | 5.5% | ||
| Q2 24 | 15.1% | — | ||
| Q1 24 | -6.5% | 21.0% |
资本支出强度OPCHSCSC
| Q4 25 | — | 0.3% | ||
| Q3 25 | 0.6% | 0.3% | ||
| Q2 25 | 0.6% | 0.3% | ||
| Q1 25 | 0.7% | 0.2% | ||
| Q4 24 | 0.8% | 0.3% | ||
| Q3 24 | 0.8% | 0.3% | ||
| Q2 24 | 0.8% | 0.2% | ||
| Q1 24 | 0.5% | 0.3% |
现金转化率OPCHSCSC
| Q4 25 | — | 1.87× | ||
| Q3 25 | 2.69× | 1.17× | ||
| Q2 25 | 1.79× | — | ||
| Q1 25 | -0.15× | 3.79× | ||
| Q4 24 | 0.60× | -0.36× | ||
| Q3 24 | 2.98× | 2.64× | ||
| Q2 24 | 3.69× | — | ||
| Q1 24 | -1.54× | 12.51× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OPCH
| Commercial Customer | $1.3B | 87% |
| Government Customer | $172.8M | 12% |
| Patient Customer | $10.1M | 1% |
| Corporate Joint Venture | $1.9M | 0% |
SCSC
| Products And Services | $723.4M | 94% |
| Intelisys Advisory | $25.0M | 3% |
| Recurring Revenue | $18.2M | 2% |
